NCT07156994 Development of Voice Biomarkers of Frequent COVID-19 and Long Covid-related Symptoms Based on Data From Users of the Long COVID Companion App
| NCT ID | NCT07156994 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Luxembourg Institute of Health |
| Condition | Long COVID |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-12-15 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The LIH DDP research team focuses its research topics on vocal biomarkers and Long COVID, among others. Voice is indeed a promising tool to monitor health, as it contains many information on our health and is easy to collect. The development of vocal biomarkers of Long COVID-related symptoms could improve the remote monitoring of the health status of people affected by this disease. The LIH developed the Long COVID Companion (LCC) app in collaboration with the ApresJ20 Long COVID patient association in France to support patients in their daily lives. LCC app users will be invited to participate in this study to collect voice recordings at the same time as health-related data. The objectives of this study are: Primary objective: To develop vocal biomarker candidates for the main Long COVID symptoms (fatigue, brain fog, respiratory problems, sleep issues, stress, anxiety,..) in a population of people with Long COVID. Secondary objectives: * to assess the intra-individual longitudinal evolution of voice characteristics of people with LC * to assess app usability and acceptability in the long-term.
Eligibility Criteria
Inclusion Criteria: * Adult (≥18 years old) * Male or female * People with persisting symptoms related to COVID-19 (With Long COVID diagnosis or not) * Adequate understanding of one of the study languages (English, French, German) * Electronically signed informed consent form Exclusion Criteria: ● No specific exclusion criteria
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07156994 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Long COVID. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07156994 currently recruiting?
Yes, NCT07156994 is actively recruiting participants. Contact the research team at aurelie.fischer@lih.lu for enrollment information.
Where is the NCT07156994 trial being conducted?
This trial is being conducted at Strassen, Luxembourg.
Who is sponsoring the NCT07156994 clinical trial?
NCT07156994 is sponsored by Luxembourg Institute of Health. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.